Search

everythinglearnresearchcommunity

for

Search:↓

PPAR activation can improve diabetic wound healing by enhancing blood vessel function.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Patients with acne and insulin resistance have different blood metabolites compared to those with only acne, which could help in diagnosis and treatment.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Lifestyle changes are more effective than metformin in reducing type 2 diabetes risk in women with PCOS.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Some common medications like metformin, insulin, and ACE inhibitors can lower PSA levels, while statins don't, and low dose finasteride significantly reduces PSA.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Dystonia may be part of PAS-4 and linked to immune issues.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Vitamin D boosts a specific gene activity in kidney cells that could improve heart and kidney function.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Drugs that block GSK-3 show promise for treating various diseases.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

5-alpha reductase inhibitors slightly increase depression risk, but the risk varies based on the control group used.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Certain genes and high cholesterol levels increase heart disease risk in Ethiopian patients with high blood pressure.

Combining D-004 and finasteride is more effective at reducing prostate enlargement than using either alone.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.